Clinical Trial Update: Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating infusion of human heterologous liver cells in children with urea cycle disorders has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbamoylphosphate Synthetase Deficiency
• Citrullinemia
• Ornithine Transcarbamylase Deficiency
• Urea Cycle Disorders

Drugs mentioned

• Human heterologous liver cell infusion

Snippet

Sponsor: Cytonet GmbH & Co. KG | Conditions: Urea Cycle Disorders, Carbamoylphosphate Synthetase I Deficiency | Phase 2 | Status: COMPLETED